Bresson-Hadni S - Search Results

1

Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis.

Spahr L, Giostra E, Frossard JL, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Spahr L, et al. J Hepatol. 2004 Aug;41(2):229-34. doi: 10.1016/j.jhep.2004.04.028. J Hepatol. 2004. PMID: 15288471

2

Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon.

Zarski JP, Maynard-Muet M, Chousterman S, Baud M, Barnoud R, Abergel A, Bacq Y, Combis JM, Causse X, Tran A, Oberti F, Minello A, Bresson-Hadni S, Bailly F, Raabe JJ, Leroy V, Hamici L, Hicham T, Girardin MF. Zarski JP, et al. Hepatology. 1998 Mar;27(3):862-7. doi: 10.1002/hep.510270332. Hepatology. 1998. PMID: 9500719 Clinical Trial.

3

Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.

Spahr L, Garcia I, Bresson-Hadni S, Rubbia-Brandt L, Guler R, Olleros M, Chvatchko Y, Hadengue A. Spahr L, et al. Liver Int. 2004 Dec;24(6):582-7. doi: 10.1111/j.1478-3231.2004.0967.x. Liver Int. 2004. PMID: 15566508

4

Allopurinol, oxidative stress and intestinal permeability in patients with cirrhosis: an open-label pilot study.

Spahr L, Bresson-Hadni S, Amann P, Kern I, Golaz O, Frossard JL, Hadengue A. Spahr L, et al. Liver Int. 2007 Feb;27(1):54-60. doi: 10.1111/j.1478-3231.2006.01382.x. Liver Int. 2007. PMID: 17241381 Clinical Trial.

5

Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study.

De Gottardi A, Thévenot T, Spahr L, Morard I, Bresson-Hadni S, Torres F, Giostra E, Hadengue A. De Gottardi A, et al. Clin Gastroenterol Hepatol. 2009 Aug;7(8):906-9. doi: 10.1016/j.cgh.2009.05.004. Epub 2009 May 15. Clin Gastroenterol Hepatol. 2009. PMID: 19447197

6

A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis.

Ambregna S, Koch S, Sulz MC, Grüner B, Öztürk S, Chevaux JB, Sulima M, de Gottardi A, Napoléon B, Abergel A, Bichard P, Boytchev I, Deprez P, Dumortier J, Frossard JL, Kull E, Meny B, Moradpour D, Prat F, Vanbiervliet G, Thevenot T, Vuitton DA, Bresson-Hadni S, Vuitton L. Ambregna S, et al. Expert Rev Anti Infect Ther. 2017 Jan;15(1):79-88. doi: 10.1080/14787210.2017.1252260. Epub 2016 Nov 7. Expert Rev Anti Infect Ther. 2017. PMID: 27788612

7

Hepatic Alveolar Echinococcosis.

Bresson-Hadni S, Spahr L, Chappuis F. Bresson-Hadni S, et al. Semin Liver Dis. 2021 Aug;41(3):393-408. doi: 10.1055/s-0041-1730925. Epub 2021 Jun 23. Semin Liver Dis. 2021. PMID: 34161992

8

A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France.

Bresson-Hadni S, Vuitton DA, Bartholomot B, Heyd B, Godart D, Meyer JP, Hrusovsky S, Becker MC, Mantion G, Lenys D, Miguet JP. Bresson-Hadni S, et al. Eur J Gastroenterol Hepatol. 2000 Mar;12(3):327-36. doi: 10.1097/00042737-200012030-00011. Eur J Gastroenterol Hepatol. 2000. PMID: 10750654

9

Place of residence and distance to medical care influence the diagnosis of hepatitis C: a population-based study.

Monnet E, Collin-Naudet E, Bresson-Hadni S, Minello A, Di Martino V, Carel D, Jooste V, Gagnaire A, Evrard P, Obert-Clerc B, Miguet JP, Hillon P. Monnet E, et al. J Hepatol. 2006 Mar;44(3):499-506. doi: 10.1016/j.jhep.2005.11.044. Epub 2005 Dec 27. J Hepatol. 2006. PMID: 16427717

10

[Update on cystic echinococcosis of the liver].

Bastid C, Terraz S, Toso C, Chappuis F, Spahr L, Bresson-Hadni S. Bastid C, et al. Among authors: bresson hadni s. Rev Med Suisse. 2021 Sep 1;17(748):1466-1473. Rev Med Suisse. 2021. PMID: 34468098 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page